Immunas Pharma, Inc.

City:

Kanagawa

Country:

Japan

Published Applications:

Last publication date:

2013-06-13

Patent Grants:

Last grant date:

2015-07-28

Top Inventors for applications by Immunas Pharma, Inc.

These are the the leading inventors for applications assigned to Immunas Pharma, Inc.:

Tatsuki Yokoseki 8 Kanagawa, Japan
Etsuro MATSUBARA 6 Aomori, Japan
Masao Shibata 3 Kanagawa, Japan
Masao Shibata 3 Nagano, Japan

Makoto Umeda 2 Kanagawa, Japan
Yukiho Imai 2 Kanagawa, Japan
Shinobu Fujii 2 Kanagawa, Japan
Yasuhide Okamoto 2 Kanagawa, Japan

Naofumi Takamatsu 2 Kanagawa, Japan
Toshiyuki Ito 2 Kanagawa, Japan
Immunas Pharma, Inc. 1 Kanagawa, Japan
National Center for Geriatrics and Gerontology 1 Aichi, Japan

Recent patent applications by Immunas Pharma, Inc.

Immunas Pharma, Inc. based in Kanagawa, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-06-13 ✅ Patent 9,090,680 granted on 2015-07-28

US20130149316A1

Chemistry; metallurgy

Antibodies that specifically bind to abeta oligomers and uses thereof

#2 | 2012-07-12 ✅ Patent 8,858,949 granted on 2014-10-14

US20120177664A1

Physics

Antibodies that specifically bind to a beta oligomers and use thereof

#3 | 2012-06-07 ✅ Patent 9,085,614 granted on 2015-07-21

US20120141477A1

Chemistry; metallurgy

Antibodies that specifically bind to Aβ oligomers and uses thereof

#4 | 2012-04-05 ✅ Patent 9,090,679 granted on 2015-07-28

US20120082667A1

Chemistry; metallurgy

Antibodies that specifically bind to A beta oligomers and use thereof

#5 | 2011-04-28

US20110097319A1

Chemistry; metallurgy

Antibody Capable of Binding Specifically to AB-Oligomer, and Use Thereof

#6 | 2010-11-18

US20100291071A1

Physics

Antibody Specific Binding to A-Beta Oligomer and the Use

#7 | 2010-10-14

US20100260783A1

Physics

Antibody Specific Binding to A Beta Oligomer and the Use

#8 | 2010-02-04 ✅ Patent 8,378,081 granted on 2013-02-19

US20100028357A1

Chemistry; metallurgy

Antibodies that specifically bind to Aβ oligomers and uses thereof

Also check out Immunas Pharma, Inc.'s (Kanagawa, Japan) applicant profile with 1 patent applications submitted.

AssigneeID:

26079 ⎘